» Articles » PMID: 12725513

Surveillance of Viral Pathogens in Australia: Respiratory Syncytial Virus

Overview
Date 2003 May 3
PMID 12725513
Citations 10
Authors
Affiliations
Soon will be listed here.
Citing Articles

Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.

Sanders S, Agwan S, Hassan M, Bont L, Venekamp R Cochrane Database Syst Rev. 2023; 10:CD009417.

PMID: 37870128 PMC: 10591280. DOI: 10.1002/14651858.CD009417.pub3.


Factors influencing health professionals' use of high-flow nasal cannula therapy for infants with bronchiolitis - A qualitative study.

OBrien S, Haskell L, Tavender E, Wilson S, Borland M, Oakley E Front Pediatr. 2023; 11:1098577.

PMID: 37009298 PMC: 10060553. DOI: 10.3389/fped.2023.1098577.


Prevalence of high flow nasal cannula therapy use for management of infants with bronchiolitis in Australia and New Zealand.

OBrien S, Haskell L, Schembri R, Gill F, Wilson S, Borland M J Paediatr Child Health. 2022; 58(12):2230-2235.

PMID: 36066264 PMC: 10947204. DOI: 10.1111/jpc.16199.


Is slide-based or video-based eLearning better at achieving behavioural change in bronchiolitis management? A cluster-based randomised control trial.

Talati R, Fonseca B, Mallitt K, Mackenzie J J Paediatr Child Health. 2022; 58(12):2177-2182.

PMID: 36054685 PMC: 10087590. DOI: 10.1111/jpc.16178.


Sustainability of evidence-based practices in the management of infants with bronchiolitis in hospital settings - a PREDICT study protocol.

Ramsden V, Babl F, Dalziel S, Middleton S, Oakley E, Haskell L BMC Health Serv Res. 2022; 22(1):1099.

PMID: 36038929 PMC: 9423692. DOI: 10.1186/s12913-022-08450-z.